🇺🇸 Prevnar13 in United States
20 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 20
Most-reported reactions
- Abdominal Discomfort — 2 reports (10%)
- Agitation — 2 reports (10%)
- Dizziness — 2 reports (10%)
- Dry Mouth — 2 reports (10%)
- Head Injury — 2 reports (10%)
- Headache — 2 reports (10%)
- Micturition Urgency — 2 reports (10%)
- Nausea — 2 reports (10%)
- Oropharyngeal Pain — 2 reports (10%)
- Somnolence — 2 reports (10%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Prevnar13 approved in United States?
Prevnar13 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prevnar13 in United States?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.